Failure of low molecular weight dextran infusions in scleroderma.
Open Access
- 1 January 1969
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 28 (1) , 49-54
- https://doi.org/10.1136/ard.28.1.49
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Scleroderma treated with dextran 40 (Rheomacrodex)Archives of Dermatology, 1966
- Renal failure associated with low-molecular-weight dextran infusion.BMJ, 1966
- Failure of ε-Aminocaproic Acid in the Treatment of SclerodermaAnnals of the Rheumatic Diseases, 1966
- THE EFFECT OF INTERMITTENT LOW MOLECULAR DEXTRAN INFUSIONS UPON THE DIGITAL CIRCULATION IN SYSTEMIC SCLEROSIS.British Journal of Dermatology, 1965
- Blood Viscosity as a Determinant of Regional Blood FlowArchives of Surgery, 1964
- Rheomacrodex in peripheral ischemiaAmerican Heart Journal, 1964
- Failure of Relaxin in the Treatment of SclerodermaAnnals of the Rheumatic Diseases, 1962
- Rheomacrodex--a new dextran solution for rheological treatment of impaired capillary flow.1961
- Treatment of scleroderma, sclerodactylia and calcinosis by chelation (EDTA)The American Journal of Medicine, 1955
- Corticotrophin and cortisone in the treatment of scleroderma.1955